Capitol Hill Briefing

How Much Should Medicare Pay for Drugs?

February 20, 2019 12:00 PM to 1:00 PM EST

2045 Rayburn House Office Building

Featuring Michael F. Cannon, Director of Health Policy Studies, Cato Institute; Peter Van Doren, Senior Fellow and Editor, Regulation, Cato Institute; moderated by Matt Weibel, Director of Government & External Affairs, Cato Institute.

Due to inclement weather, this hill briefing has been cancelled.

Join the conversation on Twitter using #CatoEvents. Follow @CatoEvents on Twitter to get future event updates, live streams, and videos from the Cato Institute. If you have questions or need assistance registering for the event, please email our staff at events@​cato.​org.

In response to bipartisan outrage over drug prices, which have risen dramatically in recent years, the Trump administration has proposed adjusting rules that determine how much the Medicare program and Medicare enrollees will pay for pharmaceuticals.

Some conservatives oppose these changes and defend the current pricing system on free‐​market grounds, arguing that reducing drug prices will necessarily reduce innovation.

What is the “right” price for prescription drugs? What is the price Medicare should pay? Join our panelists as they explain the current drug pricing system, the Trump administration’s efforts to reform it, and bipartisan ways to address the problem.